Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 603-609

  Gállego Pérez Larraya, Jaime ^a   Palma, José Alberto ^a   Carmona Iragui, María ^a   Fernández Torrón, Roberto ^a   Irimia, Pablo ^a   Rodríguez Otero, Paula ^a   Panizo, Carlos ^a   Martínez Vila, Eduardo ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Intrathecal; Liposomal cytarabine; Neurotoxicity; Non Hodgkin lymphoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; HYDROCORTISONE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ANESTHESIA (SENSORY DYSFUNCTION); ARACHNOIDITIS; ARTICLE; BRAIN PSEUDOTUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CAUDA EQUINA SYNDROME; CENTRAL NERVOUS SYSTEM TUMOR; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FECES INCONTINENCE; FEMALE; HUMAN; HYPESTHESIA; LARGE CELL LYMPHOMA; MALE; MEDICAL RECORD REVIEW; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PARESTHESIA; RETROSPECTIVE STUDY; URINE INCONTINENCE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; LIPOSOMES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; OPHTHALMOSCOPES; RETROSPECTIVE STUDIES;

EID: 79959809978     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0428-x     Document Type: Article

References (14)

1. McClune B, Buadi F, Aslam N, Przepiorka D (2007) Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma. Leuk Lymphoma 48:1849-1851 (Pubitemid 47386722)
2. Garcia-Marco JA, Panizo C, Garcia ES et al (2009) Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma. Cancer 115: 1892-1898
3. Sancho JM, Morgades M, Alonso N et al (2008) Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain. Med Clin 131:441-446
4. Chamberlain MC, Nolan C, Abrey LE (2005) Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol 75:71-83 (Pubitemid 41548680)
5. Glantz MJ, LaFollette S, Jaeckle KA et al (1999) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110-3116 (Pubitemid 29470639)
6. Kim S, Chatelut E, Kim JC et al (1993) Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 11:2186-2193 (Pubitemid 23332256)
7. Jabbour E, O'Brien S, Kantarjian H et al (2007) Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high dose methotrexate and cytarabine to patients with acute lymphoblastic leukemia. Blood 109:3214-3218 (Pubitemid 46572506)
8. Hilgendorf I, Wolff D, Junghanss C et al (2008) Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation. Ann Hematol 87:1009-1012
9. Sommer C, Lackner H, Benesch M et al (2008) Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia. Ann Hematol 87:887-890
10. Kerr JZ, Berg S, Blaney SM (2001) Intrathecal chemotherapy. Crit Rev Oncol Hematol 37:227-236
11. Pui CH, Thiel E (2009) Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol 36:2-16
12. Brazis PW, Masdeu JC, Biller J (2007) Localization in clinical neurology. Lippincott Williams & Wilkins, Philadelphia
13. Spina M, Chimienti E, Martellotta F et al (2010) Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 116:1495-1501
14. Boyd K, Jenner M, Treleaven J, Kenny J, Rhoades E (2009) Liposomal cytarabine in cerebrospinal fluid. Br J Haematol 145:679